Controllable stripping of radiolabeled group


Journal

RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657

Informations de publication

Date de publication:
02 Nov 2020
Historique:
received: 21 08 2020
accepted: 23 10 2020
entrez: 6 5 2022
pubmed: 3 11 2020
medline: 3 11 2020
Statut: epublish

Résumé

A novel "turn-off" strategy for controllable radionuclide clearance is established. 1,4-dihydropyridine (DHP) is used as a conditional linker to connect a radioisotope labeled moiety and nano-agent. A highly specific, sensitive and effective C-C bond cleavage of DHP happens

Identifiants

pubmed: 35520872
doi: 10.1039/d0ra07186b
pii: d0ra07186b
pmc: PMC9057491
doi:

Types de publication

Journal Article

Langues

eng

Pagination

40030-40034

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

There are no conflicts to declare.

Références

Biomaterials. 2010 May;31(13):3657-66
pubmed: 20138662
Chem Soc Rev. 2011 Mar;40(3):1647-71
pubmed: 21082078
Sci Signal. 2009 Apr 28;2(68):re2
pubmed: 19401594
Adv Drug Deliv Rev. 2011 Mar 18;63(3):131-5
pubmed: 20304019
Adv Mater. 2013 Jul 26;25(28):3758-79
pubmed: 23813588
Angew Chem Int Ed Engl. 2013 Sep 27;52(40):10549-52
pubmed: 23956036
J Am Chem Soc. 2013 Jan 16;135(2):703-9
pubmed: 23194416
J Nucl Med. 2005 Jun;46(6):1023-7
pubmed: 15937315
Nat Rev Drug Discov. 2010 Aug;9(8):615-27
pubmed: 20616808
Nat Chem Biol. 2016 Mar;12(3):129-37
pubmed: 26881764
Chem Rev. 2014 May 28;114(10):5161-214
pubmed: 24605868
Mol Pharm. 2008 Jul-Aug;5(4):505-15
pubmed: 18672949
Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16958-63
pubmed: 15550545
Chem Sci. 2017 Mar 1;8(3):2199-2203
pubmed: 28507674
Adv Drug Deliv Rev. 2009 Jun 21;61(6):428-37
pubmed: 19376175
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9265-9
pubmed: 2827174
Acc Chem Res. 2011 Oct 18;44(10):1050-60
pubmed: 21919457
Int J Pharm. 2006 Jan 3;307(1):93-102
pubmed: 16303268
Adv Mater. 2014 Dec 23;26(48):8210-6
pubmed: 25363309
Chem Sci. 2018 Apr 12;9(18):4268-4274
pubmed: 29780557
Adv Drug Deliv Rev. 2010 Aug 30;62(11):1064-79
pubmed: 20691229
Chem Rev. 2004 Jan;104(1):293-346
pubmed: 14719978
Chem Soc Rev. 2010 Apr;39(4):1272-9
pubmed: 20349533
Angew Chem Int Ed Engl. 2010 Apr 26;49(19):3280-94
pubmed: 20401880
Chem Rev. 2012 May 9;112(5):2739-79
pubmed: 22295941
Adv Drug Deliv Rev. 2010 Aug 30;62(11):1052-1063
pubmed: 20709124
Clin Cancer Res. 2008 Mar 1;14(5):1310-6
pubmed: 18316549

Auteurs

Hua Li (H)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Lumei Huang (L)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Hailong Jiang (H)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Jianyang Fang (J)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Zhide Guo (Z)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Fei Gao (F)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Mei Chen (M)

College of Materials Science and Engineering, Hunan University Changsha Hunan 410082 China.

Duo Xu (D)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Zijing Li (Z)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Xianzhong Zhang (X)

Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University Xiamen Fujian 361102 China zhangxzh@xmu.edu.cn zijing.li@xmu.edu.cn.

Classifications MeSH